GO:0001163 RNA polymerase I transcription regulatory region sequence-specific DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001163 describes the molecular function of sequence-specific DNA binding to regulatory regions that control RNA polymerase I (Pol I) transcription, primarily at ribosomal RNA (rRNA) gene promoters and terminators [1,2,4].
• The term is central to ribosomal RNA synthesis, a rate-limiting step for ribosome biogenesis and cell growth [4,8].
• Key proteins include UBF (UBTF), SL1 (TBP, TAF1A, TAF1B, TAF1C, TAF1D), and TTF-1 (termination factor), which recognize structured DNA elements [1,2,8].
• Species-specific transcription of rRNA genes depends on sequence-specific DNA binding by Pol I factors, as shown in human-mouse hybrid studies.
• Dysregulation of Pol I transcription is linked to cancer, ribosomopathies, and metabolic stress responses [3,5,6].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of GO:0001163-related genes in human cells and model organisms [3,6].
Description
GO:0001163, RNA polymerase I transcription regulatory region sequence-specific DNA binding, is a molecular function term that describes the binding of a protein to a specific DNA sequence within a regulatory region controlling transcription by RNA polymerase I (Pol I) [1,2]. Pol I is dedicated to the synthesis of ribosomal RNA (rRNA), and its regulatory regions include promoters, enhancers, and terminators that dictate where and how efficiently rRNA genes are transcribed [2,4]. This function is essential for ribosome biogenesis, protein synthesis, and cell growth, making it a focal point for studies of cell proliferation, stress responses, and disease [4,8]. Researchers study GO:0001163 to understand how transcription factors such as UBF and SL1 recognize DNA elements, how species-specific transcription is enforced, and how mutations in these factors contribute to cancer and ribosomopathies [1,4,8].
RNA polymerase I transcription regulatory region sequence-specific DNA binding At A Glance
| GO ID | GO:0001163 |
|---|---|
| GO term | RNA polymerase I transcription regulatory region sequence-specific DNA binding |
| Ontology | molecular_function |
| Synonym | RNA polymerase I regulatory region DNA binding |
| Definition | Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase I. |
| Major function | Sequence-specific recognition of Pol I promoter, enhancer, and terminator elements to regulate rRNA synthesis. |
| Key factors | UBF (UBTF), SL1 complex (TBP, TAF1A, TAF1B, TAF1C, TAF1D), TTF-1, and species-specific Pol I cofactors. |
| Biological context | Ribosome biogenesis, cell growth, stress response, and species-specific rRNA transcription. |
| Disease relevance | Cancer, ribosomopathies, and metabolic disorders linked to Pol I dysregulation. |
What Is GO:0001163?
GO:0001163 is defined as binding to a specific sequence of DNA that is part of a regulatory region controlling the transcription of a gene or cistron by RNA polymerase I [1,2]. In practice, this means a protein physically interacts with a defined DNA motif, such as the ribosomal RNA gene promoter or terminator, in a sequence-dependent manner to regulate Pol I transcription [1,2,4].
Why Is RNA polymerase I transcription regulatory region sequence-specific DNA binding Important in Cell Biology?
GO:0001163 is important because sequence-specific DNA binding by Pol I factors is the first committed step in ribosomal RNA synthesis, which sets the pace for ribosome production and protein synthesis capacity [4,8]. Disrupting this function alters cell growth, proliferation, and stress adaptation, and has been implicated in cancer and developmental disorders [3,5,6].
• Controls the initiation of ribosomal RNA transcription, a rate-limiting step for ribosome biogenesis [4,8].
• Enforces species-specific transcription of rRNA genes, as shown by human-mouse hybrid studies.
• Involves UBF, a sequence-tolerant HMG-box protein that recognizes structured nucleic acids.
• Requires cooperative interactions between UBF and SL1 for efficient human rRNA synthesis.
• Termination by Pol I depends on sequence-specific DNA binding at terminator elements.
• Dysregulation is linked to cancer cell proliferation and ribosomopathies [3,5,6].
• Provides a target for experimental perturbation using CRISPR knockout, point mutation, and knock-in models [3,6].
• Helps explain how environmental stress, such as cold, alters transcription factor expression.
• Enables mechanistic studies of TBP binding and sliding on nonspecific DNA.
• Supports bioinformatics and CRISPR library screening to identify regulators of Pol I transcription [3,6].
Molecular Mechanism of RNA polymerase I transcription regulatory region sequence-specific DNA binding
Recognition of the rRNA gene promoter
In simple terms: Proteins find and bind to a specific DNA sequence that starts ribosomal RNA transcription.
The first step in Pol I transcription is the sequence-specific binding of factors to the ribosomal RNA gene promoter. UBF (UBTF) binds structured DNA elements within the promoter and enhancer regions, acting as a sequence-tolerant HMG-box protein that can recognize structured nucleic acids. This binding is required for recruitment of the SL1 complex and Pol I machinery [1,8].
Cooperative assembly of UBF and SL1
In simple terms: Two protein complexes work together to lock onto the DNA and start transcription.
Functional cooperativity between UBF1 and SL1 mediates human ribosomal RNA synthesis. SL1, which contains TBP and TAF1A, TAF1B, TAF1C, and TAF1D, binds the promoter in a sequence-specific manner and recruits Pol I. This cooperative binding ensures high-fidelity initiation at the correct site.
Species-specific DNA binding
In simple terms: Different species have different DNA sequences, so their transcription factors bind only their own rRNA genes.
Molecular mechanisms governing species-specific transcription of ribosomal RNA depend on sequence-specific DNA binding by Pol I factors. Human-mouse hybrid studies showed that human SL1 and UBF cannot efficiently activate mouse rRNA genes, demonstrating that GO:0001163 activity is species-restricted.
Termination and terminator recognition
In simple terms: Proteins also bind specific DNA sequences to stop ribosomal RNA transcription.
The mechanism of transcription termination by RNA polymerase I involves sequence-specific DNA binding at terminator elements. TTF-1 binds terminator sequences and promotes release of the Pol I elongation complex, a process that requires precise DNA recognition.
TBP dynamics on nonspecific DNA
In simple terms: Even general transcription factors can slide along DNA before finding their target.
Evidence for functional binding and stable sliding of the TATA binding protein on nonspecific DNA suggests that TBP, a component of SL1, can scan DNA for regulatory regions. This sliding behavior may facilitate the search for Pol I promoter sequences in the context of GO:0001163.
Key Genes Involved in GO:0001163 RNA polymerase I transcription regulatory region sequence-specific DNA binding
The following genes encode proteins that directly or indirectly contribute to RNA polymerase I transcription regulatory region sequence-specific DNA binding (GO:0001163).
| Gene | Major Role | Research Relevance |
|---|---|---|
| UBTF | HMG-box protein that binds structured DNA in Pol I promoter and enhancer regions | Sequence-tolerant DNA binding; cooperates with SL1 [1,8] |
| TBP | TATA-binding protein subunit of SL1; binds promoter DNA and slides on nonspecific DNA | Core Pol I initiation factor; DNA sliding dynamics [7,8] |
| TAF1A | SL1 subunit; sequence-specific promoter recognition | Essential for human rRNA synthesis |
| TAF1B | SL1 subunit; promoter binding and Pol I recruitment | Species-specific transcription [4,8] |
| TAF1C | SL1 subunit; promoter binding | SL1 complex assembly |
| TAF1D | SL1 subunit; promoter binding | SL1 complex assembly |
| TTF1 | Termination factor that binds terminator DNA | Pol I termination mechanism |
| POLR1A | Largest subunit of Pol I; catalytic core | rRNA synthesis and elongation |
| POLR1B | Pol I subunit; DNA binding and catalysis | rRNA synthesis |
| POLR1C | Pol I subunit; shared with Pol III | rRNA synthesis |
| POLR1D | Pol I subunit; shared with Pol III | rRNA synthesis |
| POLR1E | Pol I subunit; promoter recruitment | rRNA synthesis |
| POLR2A | Pol II subunit; not directly Pol I but used as control | Comparative transcription studies |
| RRN3 | Pol I transcription initiation factor; bridges SL1 and Pol I | Initiation regulation |
| MYC | Oncogene that regulates Pol I transcription | Cancer and Pol I dysregulation |
| TP53 | Tumor suppressor that represses Pol I transcription | Stress response and cancer |
| CDKN2A | Cell cycle regulator linked to Pol I activity | Proliferation control |
How Is RNA polymerase I transcription regulatory region sequence-specific DNA binding Regulated?
GO:0001163 activity is regulated at multiple levels. UBF binding to DNA is modulated by its HMG-box domains and can recognize structured nucleic acids. SL1 assembly and promoter binding are influenced by TBP dynamics, including sliding on nonspecific DNA. Species-specific transcription is controlled by the compatibility of UBF and SL1 with promoter sequences. Termination by TTF-1 is regulated by terminator sequence recognition. Environmental stress, such as cold, alters expression of transcription factors in plants, suggesting that Pol I regulatory DNA binding may be stress-responsive. Nascent transcript folding can also affect Pol I elongation rates, indirectly influencing transcription output.
RNA polymerase I transcription regulatory region sequence-specific DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UBTF | Cancer, ribosomopathy | Knockout and point mutation in human cell lines [1,3] |
| TP53 | Cancer, stress response | Knockout and overexpression models |
| MYC | Cancer, proliferation | Overexpression and knock-in models |
| POLR1A | Ribosomopathy | Knockout and point mutation in zebrafish or human cells |
| TTF1 | Transcription termination defects | Knockout and tagged knock-in |
Cancer and Pol I transcription
Dysregulation of RNA polymerase I transcription is a hallmark of cancer, where increased rRNA synthesis supports rapid cell growth. Oncogenes such as MYC and tumor suppressors such as TP53 regulate Pol I activity, and sequence-specific DNA binding by UBF and SL1 is required for these effects [3,8]. Targeting GO:0001163-related factors is an emerging therapeutic strategy.
Ribosomopathies
Ribosomopathies are disorders caused by defects in ribosome biogenesis, often linked to mutations in Pol I subunits or assembly factors. Impaired sequence-specific DNA binding at rRNA gene regulatory regions can reduce rRNA synthesis and lead to developmental defects.
Metabolic and stress responses
Pol I transcription is sensitive to metabolic stress and environmental cues [5,6]. Cold stress alters expression of transcription factors in sugarcane, indicating that GO:0001163-related DNA binding may be part of stress adaptation. Nascent transcript folding also modulates Pol I elongation, linking RNA structure to transcription efficiency.
From RNA polymerase I transcription regulatory region sequence-specific DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does UBTF binding to rRNA promoter require its HMG-box domains? | Point mutation of HMG-box residues in UBTF |
| Is SL1 complex assembly essential for Pol I transcription? | Knockout of TAF1A, TAF1B, TAF1C, or TAF1D |
| How does TTF1 recognize terminator DNA? | Knock-in of tagged TTF1 and DNA binding assays |
| Does species-specific transcription depend on UBF and SL1 compatibility? | Human-mouse hybrid cells with knockout of endogenous factors |
| What is the effect of TBP sliding on promoter search? | Point mutations in TBP DNA-binding surface |
| Can overexpression of MYC drive Pol I transcription? | Overexpression of MYC in human cell lines |
How to Study the RNA polymerase I transcription regulatory region sequence-specific DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide DNA binding sites of Pol I factors | Mapping UBF, TBP, TTF1 binding [1,2,3] |
| EMSA | Direct protein-DNA binding affinity and specificity | Testing promoter and terminator sequences [1,7] |
| NET-seq | Nascent RNA and Pol I elongation rates | Measuring transcription output |
| Ribo-seq | Translation efficiency and ribosome occupancy | Assessing downstream effects |
| CRISPR screen | Gene essentiality for Pol I transcription | Identifying regulators |
| Proteomics | Protein interactions and complex composition | SL1 and UBF complex analysis |
| Live-cell imaging | Dynamic binding and sliding of TBP on DNA | Studying TBP dynamics |
| RNA-seq | Gene expression changes after perturbation | Stress response and cancer models |
Chromatin immunoprecipitation (ChIP) and ChIP-seq
ChIP with antibodies against UBF, TBP, or TTF1 identifies sequence-specific DNA binding sites at Pol I regulatory regions [1,2,3]. ChIP-seq provides genome-wide maps of binding across rRNA genes and other loci.
Electrophoretic mobility shift assay (EMSA)
EMSA measures direct binding of purified proteins to labeled DNA probes containing Pol I promoter or terminator sequences [1,7]. This method can test sequence specificity and the effect of mutations [1,7].
Nascent transcript sequencing (NET-seq) and Ribo-seq
NET-seq captures nascent RNA to measure Pol I elongation rates and transcription output. Ribo-seq measures translation and can be used to assess downstream effects of altered rRNA synthesis.
CRISPR-based genetic screens
CRISPR knockout libraries can identify genes required for Pol I transcription regulatory region binding. Bioinformatics analysis of screen data reveals pathways and networks controlling GO:0001163 activity.
How CRISPR Can Be Used to Study GO:0001163 RNA polymerase I transcription regulatory region sequence-specific DNA binding
Knockout
CRISPR knockout of UBTF, TAF1A, or TTF1 eliminates sequence-specific DNA binding at Pol I regulatory regions, allowing researchers to test loss-of-function phenotypes [1,2,8]. Knockout cell lines are valuable for studying rRNA synthesis and cell growth.
Point Mutation
Point mutations in the DNA-binding domains of UBF or TBP can disrupt specific interactions with Pol I promoter sequences without deleting the entire protein [1,7]. These models help dissect sequence-specific versus nonspecific DNA binding [1,7].
Knock-in
Knock-in of tagged versions of TTF1 or SL1 subunits enables ChIP and imaging studies of DNA binding at endogenous loci [2,8]. Tagged knock-in preserves native regulation and expression levels.
Overexpression
Overexpression of MYC or UBF can drive increased Pol I transcription and rRNA synthesis, modeling cancer-associated changes [3,8]. Overexpression models are useful for testing inhibitors of Pol I transcription.
How EDITGENE Supports RNA polymerase I transcription regulatory region sequence-specific DNA binding Research
Researchers studying RNA polymerase I transcription regulatory region sequence-specific DNA binding-related genes often need to determine whether a candidate gene is causally involved in rRNA synthesis, cell growth, or disease. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for RNA polymerase I transcription regulatory region sequence-specific DNA binding research.
Frequently Asked Questions About RNA polymerase I transcription regulatory region sequence-specific DNA binding
What is GO:0001163?
GO:0001163 is a Gene Ontology molecular function term for RNA polymerase I transcription regulatory region sequence-specific DNA binding, which describes binding to specific DNA sequences that control Pol I transcription [1,2].
What genes are involved in RNA polymerase I transcription regulatory region sequence-specific DNA binding?
Key genes include UBTF, TBP, TAF1A, TAF1B, TAF1C, TAF1D, TTF1, and POLR1A-POLR1E [1,2,8].
How does UBF bind to ribosomal RNA gene promoters?
UBF is a sequence-tolerant HMG-box protein that recognizes structured nucleic acids in Pol I promoter and enhancer regions.
What is the role of SL1 in Pol I transcription?
SL1 is a complex containing TBP and TAF1A-D that binds the promoter in a sequence-specific manner and recruits Pol I.
Why is Pol I transcription species-specific?
Species-specific transcription depends on compatible interactions between UBF, SL1, and promoter sequences, as shown in human-mouse hybrid studies.
How is Pol I transcription terminated?
Termination involves sequence-specific DNA binding by TTF-1 at terminator elements, which releases the Pol I elongation complex.
What diseases are linked to Pol I transcription dysregulation?
Cancer, ribosomopathies, and metabolic stress disorders are linked to altered Pol I transcription [3,5,6].
Can CRISPR be used to study GO:0001163?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of Pol I regulatory DNA binding [3,6].
What methods measure Pol I transcription regulatory region binding?
ChIP-seq, EMSA, NET-seq, and CRISPR screens are commonly used [1,2,3,6].
How does TBP find Pol I promoters?
TBP can bind and slide on nonspecific DNA, facilitating the search for specific promoter sequences.
Conclusion
GO:0001163, RNA polymerase I transcription regulatory region sequence-specific DNA binding, is a fundamental molecular function that governs ribosomal RNA synthesis and ribosome biogenesis [1,2,4]. Its dysregulation is linked to cancer, ribosomopathies, and stress responses, making it a critical area for research [3,5,6]. CRISPR-based models and advanced sequencing methods now allow precise dissection of this function, and EDITGENE provides the tools to accelerate discovery.
References
- 1. Copenhaver GP et al.. 1994. The RNA polymerase I transcription factor UBF is a sequence-tolerant HMG-box protein that can recognize structured nucleic acids.. Nucleic Acids Res 22(13):2651-7 PMID: 8041627
- 2. Reeder RH et al.. 1994. The mechanism of transcription termination by RNA polymerase I.. Mol Microbiol 12(1):11-5 PMID: 8057832
- 3. Rossi MJ et al.. 2021. A high-resolution protein architecture of the budding yeast genome.. Nature 592(7853):309-314 PMID: 33692541
- 4. Bell SP et al.. 1989. Molecular mechanisms governing species-specific transcription of ribosomal RNA.. Cell 59(3):489-97 PMID: 2805069
- 5. Rehman SU et al.. 2021. Expression analysis of transcription factors in sugarcane during cold stress.. Braz J Biol 83:e242603 PMID: 34932612
- 6. Turowski TW et al.. 2020. Nascent Transcript Folding Plays a Major Role in Determining RNA Polymerase Elongation Rates.. Mol Cell 79(3):488-503.e11 PMID: 32585128
- 7. Coleman RA et al.. 1995. Evidence for functional binding and stable sliding of the TATA binding protein on nonspecific DNA.. J Biol Chem 270(23):13850-9 PMID: 7775443
- 8. Bell SP et al.. 1988. Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis.. Science 241(4870):1192-7 PMID: 3413483
